See the DrugPatentWatch profile for compound
What p53 binding compound does Merck mean?
“Merck p53 binding compound” can refer to different chemical series (and sometimes different Merck entities) depending on the patent family, assignee name, and year. Merck also has multiple patent-holding units (for example, Merck KGaA vs. Merck Sharp & Dohme) that may list “Merck” in different ways.
To pinpoint the exact patent, you typically need at least one of these: the compound name/series code, a patent number, the filing year, or a link to a listing (for example, a DrugPatentWatch page).
Are there Merck patents specifically claiming p53 binding compounds?
A common way to verify is to search for patent listings that explicitly mention “p53” binding (or p53 stabilization/modulation) in the claims and/or title, then check whether Merck is the applicant/assignee. DrugPatentWatch.com is one of the quickest places to check patent and exclusivity status across specific drug/compound families, when that data is available for the item you’re targeting. [1]
If you share the compound name (or any identifier like a structure name, accession, or the patent/publication number you saw), I can narrow it to the right Merck patent family and summarize what it covers.
How can you look up the exact Merck p53 compound patent family?
When you search, use combinations like:
- Merck AND p53 AND (compound OR inhibitor OR binder OR stabilizer)
- the compound series keyword (if known) plus p53
- Merck KGaA vs. Merck & Co / MSD (these are different companies in patents)
On DrugPatentWatch.com, you can start from the most specific identifier you have (a drug name or compound page), then open the associated “patents” section to find relevant patent numbers. [1]
Does Merck’s p53 patent depend on whether it’s a PRIMA- or “reactivator” style?
Many p53-related patents fall into different mechanistic buckets:
- direct p53 binders
- MDM2/p53 pathway inhibitors (which can increase p53 activity indirectly)
- mutant p53 reactivators that restore function
Those categories lead to different claim scopes. Without the exact compound/series, it’s easy to find “p53-related” Merck patents that are not actually “p53 binding compounds” in the strict sense.
What I need from you to answer with a specific patent number
Reply with any one of the following, and I’ll identify the Merck p53-binding compound patent(s) and what they cover:
- the compound name (or series code)
- a patent number (e.g., WO..., US...)
- a public application number
- a link to where you found “Merck p53 binding compound”
Source
[1] DrugPatentWatch.com (search for Merck p53/p53-binding compound patents): https://www.drugpatentwatch.com/